Merriam v. Demoulas Super Markets, Inc.

28 Mass. L. Rptr. 284
CourtMassachusetts Superior Court
DecidedMarch 29, 2011
DocketNo. MICV201002681
StatusPublished

This text of 28 Mass. L. Rptr. 284 (Merriam v. Demoulas Super Markets, Inc.) is published on Counsel Stack Legal Research, covering Massachusetts Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Merriam v. Demoulas Super Markets, Inc., 28 Mass. L. Rptr. 284 (Mass. Ct. App. 2011).

Opinion

Haggerty, S. Jane, J.

INTRODUCTION

On June 15, 2010, the plaintiff shareholders of Demoulas Super Markets, Inc. (DSM), provided written notice to DSM’s Board of Directors of their desire to sell their DSM stock, in accordance with the stock transfer restriction provision in Article 5 of DSM’s Articles of Organization. Pursuant to Article 5, the plaintiffs appended to their written notice a proposed stock purchase agreement stating the terms upon which the plaintiffs were willing to sell their shares and, as an alternative, designated an arbitrator that the Board could select at its option to ascertain the value of the shares. On July 6, 2010, the Board (by a vote of four members out of seven) determined that the plaintiffs’ notice was invalid and took no further action. On July 14, 2010, however, the Board adopted resolutions acknowledging receipt of the notice and of the attached proposed stock purchase agreement. The Board elected not to purchase the shares on the terms set forth in the proposed agreement, but rather elected to proceed to arbitration for valuation of the shares by naming a second arbitrator, consistent with the terms of Article 5. The Board stated that it was reserving its right to contest the validity of the initial notice in the future.

On July 16, 2010, the plaintiffs filed this complaint for declaratory relief (Count I), seeking a declaration that the written notice that they provided to the Board complied with the terms of Article 5 and, further, that the Board’s decision to commence the arbitration process bars it from challenging the validity of the notice going forward. The plaintiffs also allege breach of contract (Count II), breach of the covenant of good faith and fair dealing (Count III), and, alternatively, breach of fiduciary duty (Count IV) against the four Board directors. The plaintiffs seek damages on Counts II, III and IV.

On August 6, 2010, DSM answered and asserted counterclaims for the following declarations: (1) once the Board rejected the plaintiffs’ proposed stock purchase agreement, the proposed terms were of no further effect; (2) once the arbitrators have been selected, DSM has the absolute right to purchase the shares at the value ascertained by the arbitrators without regard for the terms of the plaintiffs’ proposed agreement; (3) once the arbitration process has begun, no party has the right to terminate the arbitration process; and (4) if the proposed agreement is still in effect after its rejection by the Board, it is inconsistent with Article 5 and thus invalid (collectively, Counterclaim Count I). DSM also asserted counterclaims for the [285]*285following declarations: (5) the plaintiffs are bound by their fiduciary duties not to sell their shares to any entity that would defeat DSM’s right to qualify as a Subchapter S corporation (Counterclaim Count II); and (6) if DSM elects not to purchase the shares at the value ascertained by the arbitrators, the plaintiffs may not sell the shares to a third party at a lower value unless they first offer to sell the shares to DSM for that lower value (Counterclaim Count III).

On August 6, 2010, individual defendants Shea, Carleton, and Roazen answered and asserted counterclaims for a declaration that the plaintiffs’ notice and tender were invalid (Counterclaim Count I), or, in the alternative, for a declaration of the rights and obligations of the parties under Article 5 (Counterclaim Count II).

Defendant Darman moved to dismiss the counts against him pursuant to Mass.R.Civ.P. 12(b)(6) for failure to state a claim. The plaintiffs opposed Damian’s motion as to Counts I, II and III, but noted that they would not object to a determination by this court that, pursuant to Chokel v. Genzyme Corp., 449 Mass. 272, 275-78 (2007), contract law, rather than fiduciary law (Count IV), governs the parties’ conduct with respect to Article 5.

Thereafter, the plaintiffs moved to dismiss Count II of Shea, Carleton, and Roazen’s counterclaims for lack of standing or, alternatively, for failure to state a claim. They also moved to dismiss Counts II and III of DSM’s counterclaims for failure to state a claim.

More recently, the plaintiffs and DSM/Shea, Carlton, and Roazen cross moved for judgment on the pleadings—the plaintiffs, for declarations that their written notice was valid and that the Board waived its right to challenge the validity of the notice; DSM, for a declaration consistent with each of its counterclaims; and Shea, Carlton, and Roazen, for a declaration that the Board retains the option to purchase at the arbitrators’ price without consideration of the terms set forth in the plaintiffs’ proposed stock purchase agreement (which essentially parallels Count I of DSM’s counterclaim). Darman opposed the plaintiffs’ motion for judgment on the pleadings on the grounds set forth in his motion to dismiss.

On January 19, 2011, while the aforementioned motions were under advisement, DSM filed a motion titled “Notice of Mootness of Certain Issues in Pending Motions, in which it asserted that the arbitration process at the forefront of the dispute had concluded, thereby rendering moot the following: (1) the plaintiffs’ motion for judgment on the pleadings as to Count I of their complaint, to the extent that it seeks declarations that their notice was valid to trigger the arbitration process and that DSM waived its right to contest the validity of the notice; and (2) DSM’s cross motion for judgment on the pleadings as to Count I of its counterclaims, which seeks declarations relative to the terms and scope of arbitration. DSM contends that all that remains for the court to consider are (1) subpar-agraph 5 of prayer 2 of the plaintiffs’ request for declaratory relief, which relates to the effect of DSM’s Subchapter S status on the plaintiffs’ right to transfer their stock; and (2) Counts II and III of DSM’s counterclaims, regarding the Subchapter S issue and whether DSM retains a perpetual right of first offer under Article 5. For their part, the plaintiffs do not oppose the motion insofar as it narrows the live issues for declaratory judgment; however, they reserve the right to press forward on their claims against the individual defendants.

To summarize, the matter is before the court on (1) Plaintiffs’ motion for judgment on the pleadings as to Count I of their complaint (Pleading No. 24); (2) DSM’s and Shea, Carleton, and Roazen’s cross motions for judgment on the pleadings on their counterclaims (Pleading Nos. 25 and 26); (3) Plaintiffs’motion to dismiss Counts II and III of DSM’s counterclaims (Pleading No. 22); (4) Plaintiffs’ motion to dismiss Count II of Shea, Carleton, and Roazen’s counterclaims (Pleading No. 23); and (5) Darman’s motion to dismiss the plaintiffs’ complaint against him (Pleading No. 14).

DISCUSSION

I. Plaintiffs’ Motion for Judgment on the Pleadings as to Count I of Complaint

The plaintiffs initially sought a declaration that the written notice they provided to the Board complied with the terms of Article 5 and, further, that the Board’s decision to commence the arbitration process barred it from challenging the validity of the notice going forward. Presumably, they sought a declaration to this effect so that, in the event that the plaintiffs prevailed in their argument that the proposed terms of their written offer to sell carried forward even after arbitration, the Board would effectively be “locked in” to purchasing the stock at the arbitrators’ price and on the plaintiffs’ terms (however unreasonable they might be). Otherwise, the plaintiffs would have been free to sell to third parties.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

A.W. Chesterton Co. v. Chesterton
128 F.3d 1 (First Circuit, 1997)
Donahue v. Rodd Electrotype Co. of New England, Inc.
328 N.E.2d 505 (Massachusetts Supreme Judicial Court, 1975)
Zimmerman v. Bogoff
524 N.E.2d 849 (Massachusetts Supreme Judicial Court, 1988)
Wilkes v. Springside Nursing Home, Inc.
353 N.E.2d 657 (Massachusetts Supreme Judicial Court, 1976)
Evangelista v. Holland
537 N.E.2d 589 (Massachusetts Appeals Court, 1989)
Wood v. Baum
953 A.2d 136 (Supreme Court of Delaware, 2008)
Smith v. Atlantic Properties, Inc.
422 N.E.2d 798 (Massachusetts Appeals Court, 1981)
Fronk v. Fowler
923 N.E.2d 503 (Massachusetts Supreme Judicial Court, 2010)
Blank v. Chelmsford Ob/Gyn, P.C.
649 N.E.2d 1102 (Massachusetts Supreme Judicial Court, 1995)
Uno Restaurants, Inc. v. Boston Kenmore Realty Corp.
805 N.E.2d 957 (Massachusetts Supreme Judicial Court, 2004)
Chokel v. Genzyme Corp.
867 N.E.2d 325 (Massachusetts Supreme Judicial Court, 2007)
O'Brien v. Pearson
868 N.E.2d 118 (Massachusetts Supreme Judicial Court, 2007)
BPR Group Ltd. Partnership v. Bendetson
906 N.E.2d 956 (Massachusetts Supreme Judicial Court, 2009)
Pointer v. Castellani
455 Mass. 537 (Massachusetts Supreme Judicial Court, 2009)
O'Brien v. Pearson
851 N.E.2d 1093 (Massachusetts Appeals Court, 2006)
Knapp v. Neptune Towers Associates
892 N.E.2d 820 (Massachusetts Appeals Court, 2008)
Nahill v. Raytheon Co.
25 Mass. L. Rptr. 320 (Massachusetts Superior Court, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
28 Mass. L. Rptr. 284, Counsel Stack Legal Research, https://law.counselstack.com/opinion/merriam-v-demoulas-super-markets-inc-masssuperct-2011.